Aethlon medical publishes case studies of two critically ill covid-19 patients treated with the hemopurifier®

San diego, june 3, 2021 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical device technology company focused on unmet needs in global health, today announced the publication of a pre-print manuscript highlighting two case studies of critically ill covid-19 patients treated with the aethlon hemopurifier®. both patients were given access to hemopurifier® treatment through emergency use.
AEMD Ratings Summary
AEMD Quant Ranking